These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 17495932)

  • 21. Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites?
    Zhang S; Hüe S; Sène D; Penfornis A; Bresson-Hadni S; Kantelip B; Caillat-Zucman S; Vuitton DA
    J Infect Dis; 2008 May; 197(9):1341-9. PubMed ID: 18422447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
    Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
    J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein.
    Welte SA; Sinzger C; Lutz SZ; Singh-Jasuja H; Sampaio KL; Eknigk U; Rammensee HG; Steinle A
    Eur J Immunol; 2003 Jan; 33(1):194-203. PubMed ID: 12594848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation.
    Andresen L; Skovbakke SL; Persson G; Hagemann-Jensen M; Hansen KA; Jensen H; Skov S
    J Immunol; 2012 Feb; 188(4):1847-55. PubMed ID: 22227571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
    Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
    Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.
    Raffaghello L; Prigione I; Airoldi I; Camoriano M; Levreri I; Gambini C; Pende D; Steinle A; Ferrone S; Pistoia V
    Neoplasia; 2004; 6(5):558-68. PubMed ID: 15548365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.
    Zhang T; Barber A; Sentman CL
    Cancer Res; 2006 Jun; 66(11):5927-33. PubMed ID: 16740733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The NKG2D receptor: sensing stressed cells.
    López-Larrea C; Suárez-Alvarez B; López-Soto A; López-Vázquez A; Gonzalez S
    Trends Mol Med; 2008 Apr; 14(4):179-89. PubMed ID: 18353724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
    Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.
    Groh V; Smythe K; Dai Z; Spies T
    Nat Immunol; 2006 Jul; 7(7):755-62. PubMed ID: 16732291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner.
    Yamada N; Yamanegi K; Ohyama H; Hata M; Nakasho K; Futani H; Okamura H; Terada N
    Int J Oncol; 2012 Dec; 41(6):2005-12. PubMed ID: 22992985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
    Zhang C; Zhang J; Niu J; Zhang J; Tian Z
    Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding.
    Huergo-Zapico L; Gonzalez-Rodriguez AP; Contesti J; Gonzalez E; López-Soto A; Fernandez-Guizan A; Acebes-Huerta A; de Los Toyos JR; Lopez-Larrea C; Groh V; Spies T; Gonzalez S
    Cancer Immunol Immunother; 2012 Aug; 61(8):1201-10. PubMed ID: 22215138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How NKG2D ligands trigger autoimmunity?
    Caillat-Zucman S
    Hum Immunol; 2006 Mar; 67(3):204-7. PubMed ID: 16698443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.
    Steinle A; Li P; Morris DL; Groh V; Lanier LL; Strong RK; Spies T
    Immunogenetics; 2001; 53(4):279-87. PubMed ID: 11491531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.
    Groh V; Wu J; Yee C; Spies T
    Nature; 2002 Oct; 419(6908):734-8. PubMed ID: 12384702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
    Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma.
    Tamaki S; Kawakami M; Yamanaka Y; Shimomura H; Imai Y; Ishida J; Yamamoto K; Ishitani A; Hatake K; Kirita T
    Clin Immunol; 2009 Mar; 130(3):331-7. PubMed ID: 18951065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NKG2D ligands in tumor immunity.
    Nausch N; Cerwenka A
    Oncogene; 2008 Oct; 27(45):5944-58. PubMed ID: 18836475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four novel ULBP splice variants are ligands for human NKG2D.
    Cao W; Xi X; Wang Z; Dong L; Hao Z; Cui L; Ma C; He W
    Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.